HNGR · Hanger, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $1.12B | $1.00B | $1.10B | $1.04B | $1.04B | $1.04B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $127.75M | $118.76M | $118.06M | $109.55M | $110.08M | $107.22M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $26.90M | $28.20M | $30.60M | $29.70M | $29.70M | $31.00M |
| Operating Income | $72.67M | $71.91M | $65.43M | $59.65M | ($19.69M) | ($72.09M) |
| Interest Expense | - | - | - | $100.0K | $100.0K | $100.0K |
| Income Tax | $1.16M | $638.0K | $2.95M | $5.24M | $27.30M | ($15.91M) |
| Net Income | $41.98M | $38.19M | $27.52M | ($858.0K) | ($104.67M) | ($106.47M) |
| EPS - Basic | $1.09 | $1.01 | ($2.89) | - | - | - |
| EPS - Diluted | $1.07 | $0.99 | $0.72 | - | - | - |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $61.69M | $144.60M | $74.42M | $58.75M | $7.16M | $11.70M |
| Accounts Receivable | $152.06M | $128.60M | $159.36M | $143.99M | $125.78M | $145.60M |
| Inventory | $87.46M | $76.43M | $68.20M | $67.69M | $72.88M | $74.69M |
| Accounts Payable | $63.56M | $65.09M | $48.48M | $55.80M | $57.49M | $40.81M |
| Current Assets | $318.33M | $374.87M | $315.65M | $325.90M | $238.82M | $326.64M |
| Total Assets | $998.14M | $950.75M | $842.25M | $703.01M | $735.28M | $1.26B |
| Current Liabilities | $226.81M | $245.58M | $208.41M | $171.27M | $180.81M | $221.62M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $887.97M | $899.77M | $832.75M | $724.93M | $686.79M | $765.79M |
| Stockholders' Equity | $110.17M | $50.98M | $9.50M | ($21.92M) | $53.03M | $65.41M |
| Retained Earnings | ($252.02M) | ($294.00M) | ($331.95M) | ($361.02M) | ($275.36M) | $162.59M |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $36.21M | $155.57M | $58.85M | $78.53M | $30.11M | $68.81M |
| Investing Cash Flow | ($102.49M) | ($45.87M) | ($67.16M) | ($27.16M) | ($1.88M) | ($17.18M) |
| Financing Cash Flow | ($16.63M) | ($39.52M) | ($12.38M) | $38.97M | ($33.87M) | ($103.23M) |
| CapEx | $22.58M | $24.50M | $26.43M | $18.98M | $16.36M | $21.15M |
| Free Cash Flow | $13.63M | $131.07M | $32.41M | $59.54M | $13.75M | $47.66M |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 6.5% | 7.2% | 6.0% | 5.7% | -1.9% | -6.9% |
| EBITDA margin | 8.9% | 10.0% | 8.7% | 8.6% | 1.0% | -3.9% |
| Net margin | 3.7% | 3.8% | 2.5% | -0.1% | -10.1% | -10.2% |
| Free cash flow margin | 1.2% | 13.1% | 3.0% | 5.7% | 1.3% | 4.6% |
| FCF / Net income | 0.32 | 3.43 | 1.18 | -69.40 | -0.13 | -0.45 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 11.4% | 11.9% | 10.8% | 10.5% | 10.6% | 10.3% |
| Effective tax rate | 2.7% | 1.6% | 9.7% | 119.6% | - | - |
| Return on assets | 4.2% | 4.0% | 3.3% | -0.1% | -14.2% | -8.5% |
| Return on equity | 38.1% | 74.9% | 289.6% | 3.9% | -197.4% | -162.8% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 1.40 | 1.53 | 1.51 | 1.90 | 1.32 | 1.47 |
| Quick ratio | 1.02 | 1.22 | 1.19 | 1.51 | 0.92 | 1.14 |
| Cash ratio | 0.27 | 0.59 | 0.36 | 0.34 | 0.04 | 0.05 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | 596.5x | -196.9x | -720.9x |
| Equity multiplier | 9.06 | 18.65 | 88.62 | -32.07 | 13.87 | 19.25 |
| Liabilities / Assets | 0.89 | 0.95 | 0.99 | 1.03 | 0.93 | 0.61 |
| Efficiency | ||||||
| Asset turnover | 1.12 | 1.05 | 1.30 | 1.48 | 1.42 | 0.83 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 50d | 47d | 53d | 50d | 44d | 51d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 11.9% | -8.8% | 5.4% | 0.1% | -0.1% | - |
| Revenue CAGR (3y) | 2.4% | -1.3% | 1.8% | - | 0.9% | -0.1% |
| Revenue CAGR (5y) | 1.5% | - | 1.6% | -0.1% | 1.1% | 6.5% |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 1.1% | 9.9% | 9.7% | - | 72.7% | - |
| Net income growth (YoY) | 9.9% | 38.8% | - | 99.2% | 1.7% | - |
| EPS growth (YoY) | 8.1% | 37.5% | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | -89.6% | 304.4% | -45.6% | 333.0% | -71.1% | - |
| FCF CAGR (5y) | -22.1% | - | -5.8% | 2.7% | -23.3% | 3.3% |
| Book value growth (YoY) | 116.1% | 436.4% | - | - | -18.9% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$1.12B totalPatient Care Centers$943.33M · 84.2%
Products And Services$177.16M · 15.8%
Product / service
$1.12B totalCommercial Insurance Excluding Medicare And Medicaid Managed Care$327.84M · 29.3%
Medicare$296.33M · 26.4%
Medicaid$166.41M · 14.9%
Distribution Services Net Of Intersegment Revenue Eliminations$133.64M · 11.9%
Veterans Affairs$89.36M · 8.0%
Private Pay$63.40M · 5.7%
Therapeutic Solutions$43.52M · 3.9%
Stability scores
Altman Z′
FY 2021 · bankruptcy risk
1.25
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2021 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Specialty Outpatient Facilities, NEC
Comparing HANGER against the 5 most active filers in the same SIC group.